Post-earnings recap
Reported
Thu, Feb 27, 2025
EPS actual
$0.32
EPS est.
$0.11
EPS surprise
+190.91%
1-day move
-2.92%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a significant earnings surprise with an EPS of $0.32, but the stock reacted negatively, dropping 2.92%. This decline may reflect investor concerns despite the strong EPS performance, as revenue details were not disclosed. The lack of guidance further adds uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | N/A | +190.91% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.